Outset Medical, Inc. — Form 10-Q
Filed August 6, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 52/100
What the filing says
On August 5, 2026, Outset Medical amended its January 2025 credit agreement with Perceptive Credit Holdings IV, LP. Outstanding principal was $102.4M as of the amendment date. The warrant exercise price was adjusted from an unstated prior level to $4.838 per share, and the warrant remains exercisable for 375,000 shares (post-reverse split). Minimum revenue covenants were modified, with specific thresholds redacted as confidential.
Why this rating
Credit amendment with moderate debt restructuring (~$102M is ~31% of market cap). Warrant repricing and covenant adjustment signal refinancing need, but no principal forgiveness or maturity extension disclosed. Routine lender accommodation.
See more from August 6, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.